DVL Dorsavi LTD
Pharmaceuticals, Biotechnology & Life Sciences
Next annual general meeting
Monday 30 November 2026
Western Australia · Announced
The company has announced this date. The notice of meeting, with the agenda, is due at least 28 days before.
Last AGM voting results
Results of the AGM held Wednesday 26 November 2025.
| # | Resolution | For | Against | Result |
|---|---|---|---|---|
| 1 | Adoption of Remuneration Report | 99.99% | 0.01% | carried |
| 2 | Election of Mr Leigh Travers as a Director of the Company | 99.98% | 0.02% | carried |
| 3 | Approval to issue Performance Rights to Mr Mathew Regan | 99.92% | 0.08% | carried |
| 4 | Approval to issue Performance Rights to Mr Ed Doller | 99.92% | 0.08% | carried |
| 5 | Ratification of prior issue of Placement Shares under Listing Rule 7.1 | 99.91% | 0.09% | carried |
| 6 | Ratification of prior issue of Placement Shares under Listing Rule 7.1A | 99.90% | 0.10% | carried |
| 7 | Approval to issue Placement Options | 99.90% | 0.10% | carried |
| 8 | Approval to issue Options to 62 Capital and Evolution Capital | 99.88% | 0.12% | carried |
| 9 | Approval of 10% Placement | 99.89% | 0.11% | carried |
| 10 | Approval to issue Performance Rights to 62 Capital | 99.88% | 0.12% | carried |
| 11 | Approval to issue Shares to Dr Andrew Ronchi | 99.87% | 0.13% | carried |